BNC 210
Alternative Names: BNC-210; IW 2143Latest Information Update: 23 Jul 2024
At a glance
- Originator Bionomics
- Developer Bionomics; EmpathBio
- Class Antidepressants; Anxiolytics; Behavioural disorder therapies; Small molecules
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase III Anxiety disorders
- Phase II Agitation; Post-traumatic stress disorders
- No development reported Depressive disorders